Key Findings: This scoping review reveals that while limited studies suggest sex may influence CBD's pharmacokinetics and neuropsychiatric effects, particularly with higher plasma concentrations in females, research on gender as a moderator remains absent, highlighting a critical gap in understanding CBD's therapeutic role.
Type of Study: Meta-analysis
Study Sample Size: 12
Study Result: Inconclusive
Research Location(s): Canada
Year of Pub: 2022
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Unspecified
Citation: Matheson J, et al. Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review. Biomolecules. 2022; 12:(unknown pages). doi: 10.3390/biom12101462
Authors: Matheson J, Bourgault Z, Le Foll B